Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism.

ABSTRACT:

Background

Evidence supporting interventional pulmonary embolism (PE) treatment is needed.

Aims

We aimed to evaluate the acute safety and effectiveness of mechanical thrombectomy for intermediate- and high-risk PE in a large real-world population.

Methods

FLASH is a multicentre, prospective registry enrolling up to 1,000 US and European PE patients treated with mechanical thrombectomy using the FlowTriever System. The primary safety endpoint is a major adverse event composite including device-related death and major bleeding at 48 hours, and intraprocedural adverse events. Acute mortality and 48-hour outcomes are reported. Multivariate regression analysed characteristics associated with pulmonary artery pressure and dyspnoea improvement.

Results

Among 800 patie

SUBMITTER: Toma C 

PROVIDER: S-EPMC9936254 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature